Humpath.com - Human pathology

Most recent articles

• circulating tumor cells in lung cancer

  29 November

  References
  Circulating tumor cells in lung cancer. Young R, Pailler E, Billiot F, Drusch F, Barthelemy A, Oulhen M, Besse B, Soria JC, Farace F, Vielh P. Acta Cytol. 2012;56(6):655-60. doi:10.1159/000345182 . PMID: #23207444#

• Circulating tumor cells in prostate cancer

  29 November

  Open references
  mRNA-Seq of single prostate cancer circulating tumor cells reveals recapitulation of gene expression and pathways found in prostate cancer. Cann GM, Gulzar ZG, Cooper S, Li R, Luo S, Tat M, Stuart S, Schroth G, Srinivas S, Ronaghi M, Brooks JD, Talasaz AH. PLoS One. 2012;7(11):e49144. doi:10.1371/journal.pone.0049144 . PMID: #23145101# [Free]
  References
  Detection of circulating tumor cells in different stages of prostate cancer. Thalgott M, Rack B, Maurer T, (...)

• Circulating tumor cells in pancreatic cancer

  29 November

  References
  Circulating tumor cells in pancreatic cancer patients: methods of detection and clinical implications. Tjensvoll K, Nordgård O, Smaaland R. Int J Cancer. 2014 Jan 1;134(1):1-8. doi: 10.1002/ijc.28134. PMID: #23447365#

• isolation of circulating tumor cells by immunomagnetic enrichment and fluorescence-activated cell sorting

  29 November

  Isolation of circulating tumor cells by immunomagnetic enrichment and fluorescence-activated cell sorting (IE/FACS)
  References
  Isolation of circulating tumor cells by immunomagnetic enrichment and fluorescence-activated cell sorting (IE/FACS) for molecular profiling. Magbanua MJ, Park JW. Methods. 2013 Jul 26. doi:S1046-2023(13)00278-8. 10.1016/j.ymeth.2013.07.029 . PMID: (...)

• Neuroendocrine Differentiation in Acquired Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor

  17 October

  Neuroendocrine Differentiation in Acquired Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor. Small cell lung cancer (SCLC) transformation during epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) treatment in lung cancer
  Small cell lung cancer (SCLC) transformation during epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) treatment in lung cancer has been suggested as one of possible resistance mechanisms.
  Open references (...)

• synovial chondromatosis

  15 October

  synovial osteochondromatosis, primary synovial osteochondromatosis, synovial chondrometaplasia; Reichel’s syndrome or Reichel-Jones-Henderson syndrome, named after Friedrich Paul Reichel, Hugh Toland Jones and Melvin Starkey Henderson. WP
  Definition: Synovial chondromatosis is a disease affecting the synovium, a thin flexible membrane around a joint.

• duodenal gastric heterotopia

  15 October

  Cases
  http://lgpathology.blogspot.fr/2008/07/50-yo-male-with-duodenal-polyp.html

• Morton neuroma

  15 October

  Morton’s neuroma; Morton’s metatarsalgia, Morton’s neuralgia, plantar neuroma and intermetatarsal neuroma WP
  Definition: Morton’s neuroma is a benign neuroma of an intermetatarsal plantar nerve, most commonly of the second and third intermetatarsal spaces (between 2nd-3rd and 3rd-4th metatarsal heads).This problem is characterised by pain and/or numbness, sometimes relieved by removing footwear.
  Despite the name, the condition was first correctly described by a chiropodist named (...)

• mycophenolate-associated colitis

  14 October

  Mycophenolate mofetil (MMF) is a T-cell inhibitor frequently used in the treatment of acute allograft rejection. MMF may cause colitis that clinically and histologically resembles graft-versus-host disease (GVHD).
  A variety of histologic features, in particular, eosinophils >15 per 10 HPF, lack of endocrine cell aggregates in the lamina propria, and lack of apoptotic microabscesses, can be used by pathologists to help separate MMF from GVHD-induced colitis in routine clinical practice. (...)

• pancreatic acinar cell cystadenoma

  14 October

  Acinar cell cystadenoma of the pancreas
  Acinar cell cystadenoma (ACA) of the pancreas was initially described as a non-neoplastic cyst of the pancreas and, at that time, referred to as "acinar cystic transformation." In subsequent studies, these lesions were given the designation of "-oma," despite the relative lack of evidence supporting a neoplastic process.
  Early lesions are marked by acinar dilatation that expands into and incorporates smaller ductules and later larger ducts. As the (...)

previous page | next page